Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hooper

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Mbio|January 25, 2022
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2Joseph W Golden, Rong Li, Curtis R Cline, et al.
ACS Applied Materials & Interfaces|October 5, 2021
Photocatalytic Mechanism Control and Study of Carrier Dynamics in CdS@C<sub>3</sub>N<sub>5</sub> Core-Shell NanowiresKazi M Alam, Charles E Jensen, Pawan Kumar, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Scientific Reports|April 26, 2016
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleJohn M Dye, Hua Wu, Jay W Hooper, et al.
Antiviral Research|April 1, 2023
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamstersYu Cong, Eric M Mucker, Donna L Perry, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease lociJohn V Raelson, Randall D Little, Andreas Ruether, et al.
Plos Medicine|October 7, 2017
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trialSelidji T Agnandji, José F Fernandes, Emmanuel B Bache, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Mbio|January 25, 2022
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2Joseph W Golden, Rong Li, Curtis R Cline, et al.
ACS Applied Materials & Interfaces|October 5, 2021
Photocatalytic Mechanism Control and Study of Carrier Dynamics in CdS@C<sub>3</sub>N<sub>5</sub> Core-Shell NanowiresKazi M Alam, Charles E Jensen, Pawan Kumar, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Scientific Reports|April 26, 2016
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleJohn M Dye, Hua Wu, Jay W Hooper, et al.
Antiviral Research|April 1, 2023
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamstersYu Cong, Eric M Mucker, Donna L Perry, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease lociJohn V Raelson, Randall D Little, Andreas Ruether, et al.
Plos Medicine|October 7, 2017
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trialSelidji T Agnandji, José F Fernandes, Emmanuel B Bache, et al.
Pageof 21